aluates Reports

$ 0.0

Automative

Global Crispr Genomic Cure Market Research Report 2025

Published Date: June 2025

Report Code: QYRE-Auto-18E10114

Global Crispr Genomic Cure Market Insights Forecast to 2028

BUY CHAPTERS

Global Crispr Genomic Cure Market Research Report 2025

Code: QYRE-Auto-18E10114

Report

June 2025

Pages:88

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Abcam

Beam Therapeutics

Calyxt

Cellecta

CELLECTIS

CRISPR Therapeutics AG

Editas Medicine

Integrated DNA Technologies

Intellia Therapeutics

Merck KGaA

New England Biolabs

Precision Biosciences

Sangamo Therapeutics

Applied StemCel

ERS Genomics

Crispr Genomic Cure Market

The global market for Crispr Genomic Cure was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

North American market for Crispr Genomic Cure is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Crispr Genomic Cure is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Crispr Genomic Cure in Biomedical is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Crispr Genomic Cure include Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine, ERS Genomics, Integrated DNA Technologies, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Crispr Genomic Cure, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Crispr Genomic Cure.

The Crispr Genomic Cure market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Crispr Genomic Cure market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Crispr Genomic Cure companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Crispr Genomic Cure Market Report

Report Metric	Details
Report Name	Crispr Genomic Cure Market
Segment by Type	gRNA Design and Vector Construction Cell Line and Engineering Others
Segment by Application	Biomedical Pharmaceutical Agricultural Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine, ERS Genomics, Integrated DNA Technologies, Intellia Therapeutics, Merck KGaA, New England Biolabs, Precision BioSciences, Sangamo Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Crispr Genomic Cure company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Crispr Genomic Cure Market report?

Ans: The main players in the Crispr Genomic Cure Market are Abcam, Applied StemCel, Beam Therapeutics, CALYXT, Cellecta, Cellectis, CRISPR Therapeutics AG, Editas Medicine, ERS Genomics, Integrated DNA Technologies, Intellia Therapeutics, Merck KGaA, New England Biolabs, Precision BioSciences, Sangamo Therapeutics

What are the Application segmentation covered in the Crispr Genomic Cure Market report?

Ans: The Applications covered in the Crispr Genomic Cure Market report are Biomedical, Pharmaceutical, Agricultural, Others

What are the Type segmentation covered in the Crispr Genomic Cure Market report?

Ans: The Types covered in the Crispr Genomic Cure Market report are gRNA Design and Vector Construction, Cell Line and Engineering, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Crispr Genomic Cure Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 gRNA Design and Vector Construction

1.2.3 Cell Line and Engineering

1.2.4 Others

1.3 Market by Application

1.3.1 Global Crispr Genomic Cure Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Biomedical

1.3.3 Pharmaceutical

1.3.4 Agricultural

1.3.5 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Crispr Genomic Cure Market Perspective (2020-2031)

2.2 Global Crispr Genomic Cure Growth Trends by Region

2.2.1 Global Crispr Genomic Cure Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Crispr Genomic Cure Historic Market Size by Region (2020-2025)

2.2.3 Crispr Genomic Cure Forecasted Market Size by Region (2026-2031)

2.3 Crispr Genomic Cure Market Dynamics

2.3.1 Crispr Genomic Cure Industry Trends

2.3.2 Crispr Genomic Cure Market Drivers

2.3.3 Crispr Genomic Cure Market Challenges

2.3.4 Crispr Genomic Cure Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Crispr Genomic Cure Players by Revenue

3.1.1 Global Top Crispr Genomic Cure Players by Revenue (2020-2025)

3.1.2 Global Crispr Genomic Cure Revenue Market Share by Players (2020-2025)

3.2 Global Crispr Genomic Cure Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Crispr Genomic Cure Revenue

3.4 Global Crispr Genomic Cure Market Concentration Ratio

3.4.1 Global Crispr Genomic Cure Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Crispr Genomic Cure Revenue in 2024

3.5 Global Key Players of Crispr Genomic Cure Head office and Area Served

3.6 Global Key Players of Crispr Genomic Cure, Product and Application

3.7 Global Key Players of Crispr Genomic Cure, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Crispr Genomic Cure Breakdown Data by Type

4.1 Global Crispr Genomic Cure Historic Market Size by Type (2020-2025)

4.2 Global Crispr Genomic Cure Forecasted Market Size by Type (2026-2031)

5 Crispr Genomic Cure Breakdown Data by Application

5.1 Global Crispr Genomic Cure Historic Market Size by Application (2020-2025)

5.2 Global Crispr Genomic Cure Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Crispr Genomic Cure Market Size (2020-2031)

6.2 North America Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Crispr Genomic Cure Market Size by Country (2020-2025)

6.4 North America Crispr Genomic Cure Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Crispr Genomic Cure Market Size (2020-2031)

7.2 Europe Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Crispr Genomic Cure Market Size by Country (2020-2025)

7.4 Europe Crispr Genomic Cure Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Crispr Genomic Cure Market Size (2020-2031)

8.2 Asia-Pacific Crispr Genomic Cure Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Crispr Genomic Cure Market Size by Region (2020-2025)

8.4 Asia-Pacific Crispr Genomic Cure Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Crispr Genomic Cure Market Size (2020-2031)

9.2 Latin America Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Crispr Genomic Cure Market Size by Country (2020-2025)

9.4 Latin America Crispr Genomic Cure Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Crispr Genomic Cure Market Size (2020-2031)

10.2 Middle East & Africa Crispr Genomic Cure Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Crispr Genomic Cure Market Size by Country (2020-2025)

10.4 Middle East & Africa Crispr Genomic Cure Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abcam

11.1.1 Abcam Company Details

11.1.2 Abcam Business Overview

11.1.3 Abcam Crispr Genomic Cure Introduction

11.1.4 Abcam Revenue in Crispr Genomic Cure Business (2020-2025)

11.1.5 Abcam Recent Development

11.2 Applied StemCel

11.2.1 Applied StemCel Company Details

11.2.2 Applied StemCel Business Overview

11.2.3 Applied StemCel Crispr Genomic Cure Introduction

11.2.4 Applied StemCel Revenue in Crispr Genomic Cure Business (2020-2025)

11.2.5 Applied StemCel Recent Development

11.3 Beam Therapeutics

11.3.1 Beam Therapeutics Company Details

11.3.2 Beam Therapeutics Business Overview

11.3.3 Beam Therapeutics Crispr Genomic Cure Introduction

11.3.4 Beam Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025)

11.3.5 Beam Therapeutics Recent Development

11.4 CALYXT

11.4.1 CALYXT Company Details

11.4.2 CALYXT Business Overview

11.4.3 CALYXT Crispr Genomic Cure Introduction

11.4.4 CALYXT Revenue in Crispr Genomic Cure Business (2020-2025)

11.4.5 CALYXT Recent Development

11.5 Cellecta

11.5.1 Cellecta Company Details

11.5.2 Cellecta Business Overview

11.5.3 Cellecta Crispr Genomic Cure Introduction

11.5.4 Cellecta Revenue in Crispr Genomic Cure Business (2020-2025)

11.5.5 Cellecta Recent Development

11.6 Cellectis

11.6.1 Cellectis Company Details

11.6.2 Cellectis Business Overview

11.6.3 Cellectis Crispr Genomic Cure Introduction

11.6.4 Cellectis Revenue in Crispr Genomic Cure Business (2020-2025)

11.6.5 Cellectis Recent Development

11.7 CRISPR Therapeutics AG

11.7.1 CRISPR Therapeutics AG Company Details

11.7.2 CRISPR Therapeutics AG Business Overview

11.7.3 CRISPR Therapeutics AG Crispr Genomic Cure Introduction

11.7.4 CRISPR Therapeutics AG Revenue in Crispr Genomic Cure Business (2020-2025)

11.7.5 CRISPR Therapeutics AG Recent Development

11.8 Editas Medicine

11.8.1 Editas Medicine Company Details

11.8.2 Editas Medicine Business Overview

11.8.3 Editas Medicine Crispr Genomic Cure Introduction

11.8.4 Editas Medicine Revenue in Crispr Genomic Cure Business (2020-2025)

11.8.5 Editas Medicine Recent Development

11.9 ERS Genomics

11.9.1 ERS Genomics Company Details

11.9.2 ERS Genomics Business Overview

11.9.3 ERS Genomics Crispr Genomic Cure Introduction

11.9.4 ERS Genomics Revenue in Crispr Genomic Cure Business (2020-2025)

11.9.5 ERS Genomics Recent Development

11.10 Integrated DNA Technologies

11.10.1 Integrated DNA Technologies Company Details

11.10.2 Integrated DNA Technologies Business Overview

11.10.3 Integrated DNA Technologies Crispr Genomic Cure Introduction

11.10.4 Integrated DNA Technologies Revenue in Crispr Genomic Cure Business (2020-2025)

11.10.5 Integrated DNA Technologies Recent Development

11.11 Intellia Therapeutics

11.11.1 Intellia Therapeutics Company Details

11.11.2 Intellia Therapeutics Business Overview

11.11.3 Intellia Therapeutics Crispr Genomic Cure Introduction

11.11.4 Intellia Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025)

11.11.5 Intellia Therapeutics Recent Development

11.12 Merck KGaA

11.12.1 Merck KGaA Company Details

11.12.2 Merck KGaA Business Overview

11.12.3 Merck KGaA Crispr Genomic Cure Introduction

11.12.4 Merck KGaA Revenue in Crispr Genomic Cure Business (2020-2025)

11.12.5 Merck KGaA Recent Development

11.13 New England Biolabs

11.13.1 New England Biolabs Company Details

11.13.2 New England Biolabs Business Overview

11.13.3 New England Biolabs Crispr Genomic Cure Introduction

11.13.4 New England Biolabs Revenue in Crispr Genomic Cure Business (2020-2025)

11.13.5 New England Biolabs Recent Development

11.14 Precision BioSciences

11.14.1 Precision BioSciences Company Details

11.14.2 Precision BioSciences Business Overview

11.14.3 Precision BioSciences Crispr Genomic Cure Introduction

11.14.4 Precision BioSciences Revenue in Crispr Genomic Cure Business (2020-2025)

11.14.5 Precision BioSciences Recent Development

11.15 Sangamo Therapeutics

11.15.1 Sangamo Therapeutics Company Details

11.15.2 Sangamo Therapeutics Business Overview

11.15.3 Sangamo Therapeutics Crispr Genomic Cure Introduction

11.15.4 Sangamo Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025)

11.15.5 Sangamo Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Abcam

Beam Therapeutics

Calyxt

Cellecta

CELLECTIS

CRISPR Therapeutics AG

Editas Medicine

Integrated DNA Technologies

Intellia Therapeutics

Merck KGaA

New England Biolabs

Precision Biosciences

Sangamo Therapeutics

Applied StemCel

ERS Genomics

List of Tables

Table 1. Global Crispr Genomic Cure Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of gRNA Design and Vector Construction

Table 3. Key Players of Cell Line and Engineering

Table 4. Key Players of Others

Table 5. Global Crispr Genomic Cure Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Crispr Genomic Cure Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Crispr Genomic Cure Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Crispr Genomic Cure Market Share by Region (2020-2025)

Table 9. Global Crispr Genomic Cure Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Crispr Genomic Cure Market Share by Region (2026-2031)

Table 11. Crispr Genomic Cure Market Trends

Table 12. Crispr Genomic Cure Market Drivers

Table 13. Crispr Genomic Cure Market Challenges

Table 14. Crispr Genomic Cure Market Restraints

Table 15. Global Crispr Genomic Cure Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Crispr Genomic Cure Market Share by Players (2020-2025)

Table 17. Global Top Crispr Genomic Cure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crispr Genomic Cure as of 2024)

Table 18. Ranking of Global Top Crispr Genomic Cure Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Crispr Genomic Cure Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Crispr Genomic Cure, Headquarters and Area Served

Table 21. Global Key Players of Crispr Genomic Cure, Product and Application

Table 22. Global Key Players of Crispr Genomic Cure, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Crispr Genomic Cure Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Crispr Genomic Cure Revenue Market Share by Type (2020-2025)

Table 26. Global Crispr Genomic Cure Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Crispr Genomic Cure Revenue Market Share by Type (2026-2031)

Table 28. Global Crispr Genomic Cure Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Crispr Genomic Cure Revenue Market Share by Application (2020-2025)

Table 30. Global Crispr Genomic Cure Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Crispr Genomic Cure Revenue Market Share by Application (2026-2031)

Table 32. North America Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Crispr Genomic Cure Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Crispr Genomic Cure Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Crispr Genomic Cure Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Crispr Genomic Cure Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Crispr Genomic Cure Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Crispr Genomic Cure Market Size by Country (2026-2031) & (US$ Million)

Table 47. Abcam Company Details

Table 48. Abcam Business Overview

Table 49. Abcam Crispr Genomic Cure Product

Table 50. Abcam Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 51. Abcam Recent Development

Table 52. Applied StemCel Company Details

Table 53. Applied StemCel Business Overview

Table 54. Applied StemCel Crispr Genomic Cure Product

Table 55. Applied StemCel Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 56. Applied StemCel Recent Development

Table 57. Beam Therapeutics Company Details

Table 58. Beam Therapeutics Business Overview

Table 59. Beam Therapeutics Crispr Genomic Cure Product

Table 60. Beam Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 61. Beam Therapeutics Recent Development

Table 62. CALYXT Company Details

Table 63. CALYXT Business Overview

Table 64. CALYXT Crispr Genomic Cure Product

Table 65. CALYXT Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 66. CALYXT Recent Development

Table 67. Cellecta Company Details

Table 68. Cellecta Business Overview

Table 69. Cellecta Crispr Genomic Cure Product

Table 70. Cellecta Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 71. Cellecta Recent Development

Table 72. Cellectis Company Details

Table 73. Cellectis Business Overview

Table 74. Cellectis Crispr Genomic Cure Product

Table 75. Cellectis Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 76. Cellectis Recent Development

Table 77. CRISPR Therapeutics AG Company Details

Table 78. CRISPR Therapeutics AG Business Overview

Table 79. CRISPR Therapeutics AG Crispr Genomic Cure Product

Table 80. CRISPR Therapeutics AG Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 81. CRISPR Therapeutics AG Recent Development

Table 82. Editas Medicine Company Details

Table 83. Editas Medicine Business Overview

Table 84. Editas Medicine Crispr Genomic Cure Product

Table 85. Editas Medicine Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 86. Editas Medicine Recent Development

Table 87. ERS Genomics Company Details

Table 88. ERS Genomics Business Overview

Table 89. ERS Genomics Crispr Genomic Cure Product

Table 90. ERS Genomics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 91. ERS Genomics Recent Development

Table 92. Integrated DNA Technologies Company Details

Table 93. Integrated DNA Technologies Business Overview

Table 94. Integrated DNA Technologies Crispr Genomic Cure Product

Table 95. Integrated DNA Technologies Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 96. Integrated DNA Technologies Recent Development

Table 97. Intellia Therapeutics Company Details

Table 98. Intellia Therapeutics Business Overview

Table 99. Intellia Therapeutics Crispr Genomic Cure Product

Table 100. Intellia Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 101. Intellia Therapeutics Recent Development

Table 102. Merck KGaA Company Details

Table 103. Merck KGaA Business Overview

Table 104. Merck KGaA Crispr Genomic Cure Product

Table 105. Merck KGaA Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 106. Merck KGaA Recent Development

Table 107. New England Biolabs Company Details

Table 108. New England Biolabs Business Overview

Table 109. New England Biolabs Crispr Genomic Cure Product

Table 110. New England Biolabs Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 111. New England Biolabs Recent Development

Table 112. Precision BioSciences Company Details

Table 113. Precision BioSciences Business Overview

Table 114. Precision BioSciences Crispr Genomic Cure Product

Table 115. Precision BioSciences Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 116. Precision BioSciences Recent Development

Table 117. Sangamo Therapeutics Company Details

Table 118. Sangamo Therapeutics Business Overview

Table 119. Sangamo Therapeutics Crispr Genomic Cure Product

Table 120. Sangamo Therapeutics Revenue in Crispr Genomic Cure Business (2020-2025) & (US$ Million)

Table 121. Sangamo Therapeutics Recent Development

Table 122. Research Programs/Design for This Report

Table 123. Key Data Information from Secondary Sources

Table 124. Key Data Information from Primary Sources

Table 125. Authors List of This Report

List of Figures

Figure 1. Crispr Genomic Cure Picture

Figure 2. Global Crispr Genomic Cure Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Crispr Genomic Cure Market Share by Type: 2024 VS 2031

Figure 4. gRNA Design and Vector Construction Features

Figure 5. Cell Line and Engineering Features

Figure 6. Others Features

Figure 7. Global Crispr Genomic Cure Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Crispr Genomic Cure Market Share by Application: 2024 VS 2031

Figure 9. Biomedical Case Studies

Figure 10. Pharmaceutical Case Studies

Figure 11. Agricultural Case Studies

Figure 12. Others Case Studies

Figure 13. Crispr Genomic Cure Report Years Considered

Figure 14. Global Crispr Genomic Cure Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 15. Global Crispr Genomic Cure Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 16. Global Crispr Genomic Cure Market Share by Region: 2024 VS 2031

Figure 17. Global Crispr Genomic Cure Market Share by Players in 2024

Figure 18. Global Top Crispr Genomic Cure Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Crispr Genomic Cure as of 2024)

Figure 19. The Top 10 and 5 Players Market Share by Crispr Genomic Cure Revenue in 2024

Figure 20. North America Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 21. North America Crispr Genomic Cure Market Share by Country (2020-2031)

Figure 22. United States Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Canada Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Crispr Genomic Cure Market Share by Country (2020-2031)

Figure 26. Germany Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. France Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. U.K. Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Italy Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Russia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Nordic Countries Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Crispr Genomic Cure Market Share by Region (2020-2031)

Figure 34. China Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Japan Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. South Korea Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Southeast Asia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. India Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Australia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Crispr Genomic Cure Market Share by Country (2020-2031)

Figure 42. Mexico Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Brazil Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Crispr Genomic Cure Market Share by Country (2020-2031)

Figure 46. Turkey Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Saudi Arabia Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. UAE Crispr Genomic Cure Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Abcam Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 50. Applied StemCel Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 51. Beam Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 52. CALYXT Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 53. Cellecta Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 54. Cellectis Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 55. CRISPR Therapeutics AG Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 56. Editas Medicine Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 57. ERS Genomics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 58. Integrated DNA Technologies Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 59. Intellia Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 60. Merck KGaA Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 61. New England Biolabs Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 62. Precision BioSciences Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 63. Sangamo Therapeutics Revenue Growth Rate in Crispr Genomic Cure Business (2020-2025)

Figure 64. Bottom-up and Top-down Approaches for This Report

Figure 65. Data Triangulation

Figure 66. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global CRISPR Nucleases Market Research Report 2024

Global CRISPR Cas9 Gene Editing Service Market Research Report 2025

Global CRISPR PE Technology Market Research Report 2024

Global CRISPR Gene Detection and Diagnostic Market Research Report 2024

Global CRISPR Cas9 Nuclease Market Research Report 2024

Global CRISPR Gene Testing and Diagnostics Market Research Report 2024

Global Gene Editing Therapy Market Research Report 2024

Global Crisper Related Nuclease Market Research Report 2024

Global CRISPR Based Therapeutics Market Research Report 2024

Global Genome Editing Techniques Market Research Report 2024

Global Genome Engineering Editing Market Research Report 2024

Global Genomic Testing in Cancer Market Research Report 2024

Global Cancer Genomic Testing Market Research Report 2024

Global CRISPR Isothermal Amplification Gene Detection Technology Market Research Report 2024

Genome Editing Services Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CAS9 Technology Market Research Report 2024

Global CRISPR Genome Editing Market Insights Forecast to 2030

Global Optogenetic Gene Therapy Market Research Report 2024

Global Epigenetic Therapeutics Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions